Fuller & Thaler Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-255,520
| Closed | -$2.96M | – | 498 |
|
|
2022
Q1 | $2.96M | Buy |
255,520
+1,325
| +0.5% | +$15.3K | 0.02% | 326 |
|
|
2021
Q4 | $2.82M | Buy |
254,195
+1,225
| +0.5% | +$13.6K | 0.02% | 327 |
|
|
2021
Q3 | $2.33M | Sell |
252,970
-1,025
| -0.4% | -$9.45K | 0.02% | 335 |
|
|
2021
Q2 | $2.86M | Buy |
253,995
+94,497
| +59% | +$1.06M | 0.02% | 310 |
|
|
2021
Q1 | $1.69M | Sell |
159,498
-14,715
| -8% | -$156K | 0.01% | 344 |
|
|
2020
Q4 | $1.89M | Sell |
174,213
-9,145
| -5% | -$99.2K | 0.02% | 332 |
|
|
2020
Q3 | $1.78M | Sell |
183,358
-10,180
| -5% | -$98.9K | 0.02% | 303 |
|
|
2020
Q2 | $1.54M | Sell |
193,538
-4,960
| -2% | -$39.5K | 0.02% | 308 |
|
|
2020
Q1 | $1.73M | Buy |
198,498
+17,428
| +10% | +$151K | 0.03% | 280 |
|
|
2019
Q4 | $2.05M | Buy |
181,070
+500
| +0.3% | +$5.66K | 0.02% | 290 |
|
|
2019
Q3 | $1.96M | Buy |
+180,570
| New | +$1.96M | 0.02% | 286 |
|
|
2018
Q3 | – | Sell |
-171,350
| Closed | -$2.55M | – | 605 |
|
|
2018
Q2 | $2.55M | Hold |
171,350
| – | – | 0.03% | 276 |
|
|
2018
Q1 | $2.24M | Sell |
171,350
-12,600
| -7% | -$164K | 0.03% | 269 |
|
|
2017
Q4 | $2.32M | Sell |
183,950
-58,100
| -24% | -$732K | 0.03% | 251 |
|
|
2017
Q3 | $3.14M | Sell |
242,050
-1,200
| -0.5% | -$15.5K | 0.04% | 206 |
|
|
2017
Q2 | $3.61M | Sell |
243,250
-800
| -0.3% | -$11.9K | 0.05% | 181 |
|
|
2017
Q1 | $2.93M | Hold |
244,050
| – | – | 0.04% | 185 |
|
|
2016
Q4 | $3.37M | Buy |
244,050
+212,850
| +682% | +$2.94M | 0.05% | 170 |
|
|
2016
Q3 | $418K | Buy |
+31,200
| New | +$418K | 0.01% | 282 |
|